As MALAT1 depletion markedly enhances cellular sensitivity to PARPi, we examined the effect of olaparib treatment on cell-cycle profiles in MALAT1-silenced prostate cancer cells by performing EdU staining. The gene discussed is MALAT1; the disease is prostate carcinoma.